CFM
TNYA icon

Catalyst Funds Management’s Tenaya Therapeutics TNYA Stock Holding History

Catalyst Funds Management’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$23K Buy
+33,200
New +$24.5K ﹤0.01% 572
2024
Q2 		– Sell
-733
Closed -$3.83K – 1593
2024
Q1 		$3.83K Buy
+733
New +$3.51K ﹤0.01% 1004

Other funds holding TNYA

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.02B AUM 85.32% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Catalyst Funds Management's TNYA Position: Q1 2026 in Review

Catalyst Funds Management opened a new position in Tenaya Therapeutics (TNYA) in Q1 2026: 33,200 shares worth $23K. The stake represents ﹤0.01% of the portfolio and ranks #572 among its holdings. This is a return to the name: Catalyst Funds Management previously reported a position in TNYA as recently as Q1 2024.

Catalyst Funds Management first reported a position in TNYA in Q1 2024 and has held it in 2 quarters since. 103 funds tracked by Wall St. Rank hold TNYA as of Q1 2026.

  • Catalyst Funds Management held 33,200 shares of Tenaya Therapeutics worth $23K as of Q1 2026.
  • Tenaya Therapeutics was a new Catalyst Funds Management position in Q1 2026.
  • Tenaya Therapeutics made up ﹤0.01% of Catalyst Funds Management's portfolio in Q1 2026, its #572 holding.
  • Catalyst Funds Management first reported a position in Tenaya Therapeutics in Q1 2024 and has held it in 2 quarters since.
  • 103 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q1 2026.

Based on Catalyst Funds Management's 13F filing for Q1 2026, filed 11 May 2026.